Cross Talk between Wnt/β-Catenin and CIP2A/Plk1 Signaling in Prostate Cancer: Promising Therapeutic Implications

Yazar: Cristóbal, Ion, Rojo, Federico, Madoz-Gúrpide, Juan, García-Foncillas, Jesús
Yayımlandı Mol Cell Biol (2016)

Potential therapeutic value of miR‐425‐5p in metastatic colorectal cancer

Yazar: Cristóbal, Ion, Madoz‐Gúrpide, Juan, Rojo, Federico, García‐Foncillas, Jesús
Yayımlandı J Cell Mol Med (2016)

Comment on ‘MicroRNA-214 suppresses growth, migration and invasion through a novel target, high mobility group AT-hook 1, in human cervical and colorectal cancer cells’

Yazar: Cristóbal, Ion, Torrejón, Blanca, Madoz-Gúrpide, Juan, Rojo, Federico, García-Foncillas, Jesús
Yayımlandı Br J Cancer (2017)

Thymidylate synthase expression as a predictive biomarker of pemetrexed sensitivity in advanced non-small cell lung cancer

Yazar: Chamizo, Cristina, Zazo, Sandra, Dómine, Manuel, Cristóbal, Ion, García-Foncillas, Jesús, Rojo, Federico, Madoz-Gúrpide, Juan
Yayımlandı BMC Pulm Med (2015)

Functional and Clinical Impact of CircRNAs in Oral Cancer

Yazar: Cristóbal, Ion, Caramés, Cristina, Rubio, Jaime, Sanz-Alvarez, Marta, Luque, Melani, Madoz-Gúrpide, Juan, Rojo, Federico, García-Foncillas, Jesús
Yayımlandı Cancers (Basel) (2020)

Activation of MET pathway predicts poor outcome to cetuximab in patients with recurrent or metastatic head and neck cancer

Yazar: Madoz-Gúrpide, Juan, Zazo, Sandra, Chamizo, Cristina, Casado, Victoria, Caramés, Cristina, Gavín, Eduardo, Cristóbal, Ion, García-Foncillas, Jesús, Rojo, Federico
Yayımlandı J Transl Med (2015)

Activation of the Tumor Suppressor PP2A Emerges as a Potential Therapeutic Strategy for Treating Prostate Cancer

Yazar: Cristóbal, Ion, González-Alonso, Paula, Daoud, Lina, Solano, Esther, Torrejón, Blanca, Manso, Rebeca, Madoz-Gúrpide, Juan, Rojo, Federico, García-Foncillas, Jesús
Yayımlandı Mar Drugs (2015)

Downregulation of microRNA-199b predicts unfavorable prognosis and emerges as a novel therapeutic target which contributes to PP2A inhibition in metastatic colorectal cancer

Yazar: Cristóbal, Ion, Caramés, Cristina, Rincón, Raúl, Manso, Rebeca, Madoz-Gúrpide, Juan, Torrejón, Blanca, González-Alonso, Paula, Rojo, Federico, García-Foncillas, Jesús
Yayımlandı Oncotarget (2016)

Low MicroRNA-19b Expression Shows a Promising Clinical Impact in Locally Advanced Rectal Cancer

Yazar: Rubio, Jaime, Cristóbal, Ion, Santos, Andrea, Caramés, Cristina, Luque, Melani, Sanz-Alvarez, Marta, Zazo, Sandra, Madoz-Gúrpide, Juan, Rojo, Federico, García-Foncillas, Jesús
Yayımlandı Cancers (Basel) (2021)

The Novel Oral mTORC1/2 Inhibitor TAK-228 Reverses Trastuzumab Resistance in HER2-Positive Breast Cancer Models

Yazar: Sanz-Álvarez, Marta, Martín-Aparicio, Ester, Luque, Melani, Zazo, Sandra, Martínez-Useros, Javier, Eroles, Pilar, Rovira, Ana, Albanell, Joan, Madoz-Gúrpide, Juan, Rojo, Federico
Yayımlandı Cancers (Basel) (2021)

Generation, characterization, and maintenance of trastuzumab-resistant HER2+ breast cancer cell lines

Yazar: Zazo, Sandra, González-Alonso, Paula, Martín-Aparicio, Ester, Chamizo, Cristina, Cristóbal, Ion, Arpí, Oriol, Rovira, Ana, Albanell, Joan, Eroles, Pilar, Lluch, Ana, Madoz-Gúrpide, Juan, Rojo, Federico
Yayımlandı Am J Cancer Res (2016)

Deregulation of SET is Associated with Tumor Progression and Predicts Adverse Outcome in Patients with Early-Stage Colorectal Cancer

Yazar: Cristóbal, Ion, Torrejón, Blanca, Rubio, Jaime, Santos, Andrea, Pedregal, Manuel, Caramés, Cristina, Zazo, Sandra, Luque, Melani, Sanz-Alvarez, Marta, Madoz-Gúrpide, Juan, Rojo, Federico, García-Foncillas, Jesús
Yayımlandı J Clin Med (2019)

MicroRNA-199b Deregulation Shows a Strong SET-Independent Prognostic Value in Early-Stage Colorectal Cancer

Yazar: Cristóbal, Ion, Rubio, Jaime, Torrejón, Blanca, Santos, Andrea, Caramés, Cristina, Luque, Melani, Sanz-Álvarez, Marta, Alonso, Ruth, Zazo, Sandra, Madoz-Gúrpide, Juan, Rojo, Federico, García-Foncillas, Jesús
Yayımlandı J Clin Med (2020)

PP2A inhibition determines poor outcome and doxorubicin resistance in early breast cancer and its activation shows promising therapeutic effects

Yazar: Rincón, Raúl, Cristóbal, Ion, Zazo, Sandra, Arpí, Oriol, Menéndez, Silvia, Manso, Rebeca, Lluch, Ana, Eroles, Pilar, Rovira, Ana, Albanell, Joan, García-Foncillas, Jesús, Madoz-Gúrpide, Juan, Rojo, Federico
Yayımlandı Oncotarget (2015)

Pyrosequencing-Based Assays for Rapid Detection of HER2 and HER3 Mutations in Clinical Samples Uncover an E332E Mutation Affecting HER3 in Retroperitoneal Leiomyosarcoma

Yazar: González-Alonso, Paula, Chamizo, Cristina, Moreno, Víctor, Madoz-Gúrpide, Juan, Carvajal, Nerea, Daoud, Lina, Zazo, Sandra, Martín-Aparicio, Ester, Cristóbal, Ion, Rincón, Raúl, García-Foncillas, Jesús, Rojo, Federico
Yayımlandı Int J Mol Sci (2015)

Expression of Phosphorylated BRD4 Is Markedly Associated with the Activation Status of the PP2A Pathway and Shows a Strong Prognostic Value in Triple Negative Breast Cancer Patient...

Yazar: Sanz-Álvarez, Marta, Cristóbal, Ion, Luque, Melani, Santos, Andrea, Zazo, Sandra, Madoz-Gúrpide, Juan, Caramés, Cristina, Chiang, Cheng-Ming, García-Foncillas, Jesús, Eroles, Pilar, Albanell, Joan, Rojo, Federico
Yayımlandı Cancers (Basel) (2021)

MicroRNA-199b Downregulation Confers Resistance to 5-Fluorouracil Treatment and Predicts Poor Outcome and Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cance...

Yazar: Cristóbal, Ion, Rubio, Jaime, Santos, Andrea, Torrejón, Blanca, Caramés, Cristina, Imedio, Laura, Mariblanca, Sofía, Luque, Melani, Sanz-Alvarez, Marta, Zazo, Sandra, Madoz-Gúrpide, Juan, Rojo, Federico, García-Foncillas, Jesús
Yayımlandı Cancers (Basel) (2020)

The miRNA-449 family mediates doxorubicin resistance in triple-negative breast cancer by regulating cell cycle factors

Yazar: Tormo, Eduardo, Ballester, Sandra, Adam-Artigues, Anna, Burgués, Octavio, Alonso, Elisa, Bermejo, Begoña, Menéndez, Silvia, Zazo, Sandra, Madoz-Gúrpide, Juan, Rovira, Ana, Albanell, Joan, Rojo, Federico, Lluch, Ana, Eroles, Pilar
Yayımlandı Sci Rep (2019)

The Hippo Pathway Transducers YAP1/TEAD Induce Acquired Resistance to Trastuzumab in HER2-Positive Breast Cancer

Yazar: González-Alonso, Paula, Zazo, Sandra, Martín-Aparicio, Ester, Luque, Melani, Chamizo, Cristina, Sanz-Álvarez, Marta, Minguez, Pablo, Gómez-López, Gonzalo, Cristóbal, Ion, Caramés, Cristina, García-Foncillas, Jesús, Eroles, Pilar, Lluch, Ana, Arpí, Oriol, Rovira, Ana, Albanell, Joan, Piersma, Sander R., Jimenez, Connie R., Madoz-Gúrpide, Juan, Rojo, Federico
Yayımlandı Cancers (Basel) (2020)